Jose Jimenez (José Jiménez Flores)

Years Active: 2022-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Nikaoly Ciriaco, Esther Zamora Adelantado, Santiago Escriva-de-Romani, Ignacio Miranda Gómez, Jose Jimenez, Cristina Saura, Hillary Sloane, Anna Starus, Johannes Fredebohm, Lucy Georgieva, Graham Speight, Frederick Jones, Santiago Ramón Y Cajal, Martín Espinosa-Bravo, Vicente Peg
Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response. Therapeutic advances in medical oncology 14 (2022)
Joan Frigola, Caterina Carbonell, Patricia Irazno, Nuria Pardo, Ana Callejo, Susana Cedres, Alex Martinez-Marti, Alejandro Navarro, Mireia Soleda, Jose Jimenez, Javier Hernandez-Losa, Ana Vivancos, Enriqueta Felip, Ramon Amat
High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC. Journal for immunotherapy of cancer 10 (4) (2022)

Jose Jimenez.css-eqlu8i{font-size:small;padding-left:4px;} (José Jiménez Flores)